【利好】明年起我国对部分药品生产原料实施进口零关税_媒体报道_News

News Media coverage Industry information

【利好】明年起我国对部分药品生产原料实施进口零关税

Time：2019-01-02

值得注意的是，在706项进口暂定税率调整商品中，地西他滨、奥替拉西钾、来那度胺等多种抗癌药原料和青霉胺、吡非尼酮、利鲁唑、波生坦等多种罕见病药原料将实施零关税。此外，即将实施零关税的药品还包括了胰岛素、免疫制品、抗血清及其他血份、人用疫苗、遗传物质和基因修饰生物体、具有抗癌作用的含有生物碱及其衍生物的药品等。

About us: Company Profile; History; Honors

Corporate Culture: Enterprise values; Company vision; Our Team

News: News; Media coverage; Industry information

Products: US GMP Facility; EU GMP Facility; PIC/S GMP, and China GMP Facility; US, EU, and China GMP Facility; US, EU, and China GMP Facility (Biological Product-1); US, EU, and China GMP Facility (Biological Product-2)

Group Members: Guangzhou Greensyn Pharma Co,.Ltd.; Guangzhou Greensyn Chemicals Co., Ltd.; Zocura Pharma(Guangzhou)Co.,Ltd.

Careers

Marketing Center

Contact Us: Feedback; Contact

020-82512303

RM 614-616, District D, Guangzhou Technology Innovation Base, 80# Lan Yue Road, Guangzhou Science City